Global Period Health Tech Market Size (2024 – 2030)

The Global Period Health Tech Market had an initial valuation of USD 6.37 billion and is expected to achieve a market size of USD 18 billion by the conclusion of 2030. Forecasted for the period spanning from 2024 to 2030, the market anticipates a growth rate of 16%.

Industry Overview

The improvement of women's healthcare yields positive outcomes for patients and consumers, investors, and all stakeholders within the value chain, benefiting society holistically. A detailed examination of these prospects, alongside the broader context within which they have emerged, is outlined in the post "Unlocking Opportunities in Women's Healthcare." This article now directs its focus toward FemTech, elucidating its definition, recognizing its substantial growth to date, and exploring its potential to more effectively align resources, expertise, and investments with the unmet healthcare needs of women.

Historically, women's health has often been marginalized as a specialized sector, lacking a distinct technological market tailored to its needs. Additionally, ventures that exclusively targeted products for female consumers faced challenges. However, the landscape is evolving, propelled by the rise of the 'she-economy.' Women are assuming increasingly pivotal roles as consumers, decision-makers, healthcare providers, and caregivers within the healthcare sphere. Consequently, FemTech has emerged as a response to various startups and enterprises identifying this existing gap. This category, encompassing software, diagnostics, products, and services, utilizes technology to enhance the health and well-being of women. It embodies the application of digital health solutions specifically tailored to improve women's health outcomes.

Impact of COVID-19 on the Industry

Collaborative efforts between pharmaceutical, biotech industries, and governments worldwide are underway to combat the COVID-19 pandemic, spanning from vaccine research to planning pharmaceutical supply chains. Currently, there are approximately 115 vaccine candidates and 155 compounds in the R&D pipeline. Moreover, medications such as Hydroxychloroquine, typically used for other purposes, have experienced a significant surge in demand for COVID-19 treatment. The escalating demand has created substantial opportunities for developers of COVID-19 management therapies, especially considering the scarcity experienced by many affluent nations in acquiring these medications. The pharmaceutical and biotechnology sectors are poised for significant expansion owing to the demand for COVID-19 vaccines and treatment medications, with far-reaching implications.

Market Drivers

Rise in the digitization of healthcare:

Breakthrough FemTech solutions have spurred increased market demand for services like embryo screening, egg freezing, and fertility treatments. Additionally, the advent of wearable devices for patient monitoring is expected to drive utilization in the coming years. The availability of such technologically advanced devices will fuel market growth during the forecast period.

Development of software solutions:

This segment of the FemTech market comprises equipment, software, and services. The rising prevalence of chronic and infectious diseases among women will escalate the demand for improved diagnostic and treatment modalities, propelling segmental growth. Furthermore, continuous efforts by enterprises to innovate and introduce technologically advanced approaches for enhancing women's health and well-being will bolster industry expansion. Advancements in women's health products such as tampons, breast pumps, and pelvic floor exercise devices will further contribute to market growth.

Increasing Government Initiatives for Menstrual Hygiene:

Enhanced consumer awareness regarding menstrual hygiene, coupled with rising numbers of working women and income levels, are primary drivers propelling the global expansion of feminine hygiene products such as tampons, sanitary pads, and menstrual cups. Additionally, government initiatives to provide free sanitary pads, especially in economically challenged nations, have spurred international growth in the feminine hygiene sector. For instance, the Japanese government allocated JPY 1.3 billion in March 2021 to assist women in need of menstrual supplies, further supporting local governments in offering free sanitary pads and tampons to citizens.

Market Restraints

Limited awareness among women about FemTech products and their utility may hinder industry progress, particularly in developing nations:

Menstruation remains a taboo subject, contributing to misinformation and harmful misconceptions, thereby impeding individuals who require guidance or medical assistance. FemTech is spotlighting women in an industry where their needs have often been overlooked. Misconceptions and disparities in women's health have persisted over the years, with many clinical studies historically skewed towards male subjects, resulting in limited data on women's healthcare. However, FemTech, with its exclusive focus on women, addresses these challenges comprehensively—from menstruation to menopause and pregnancy—through education and personalized services and products.

Global Period Health Tech Market - Product Types

• Mobile Applications
• Software
• Hardware

The segmentation of the market into product categories includes Mobile Applications, Software, and Hardware. Presently, Mobile Applications designed for menstrual cycle tracking exhibit the highest market share among the various product types.

Global Period Health Tech Market - Regional Breakdown

• Asia-Pacific
• North America
• Europe
• Latin America
• The Middle East and Africa

Various enterprises have introduced diverse lines of feminine hygiene products tailored for distinct socioeconomic demographics. Within the Asia-Pacific region, China's domestic market for sanitary pads stands as the largest. Despite relatively lower awareness concerning hygiene products in Asian markets, numerous opportunities exist for enterprises to explore or enter. Responding to the increasing demand for feminine hygiene products, manufacturers in the Asia-Pacific region are introducing a range of supplementary goods. Market participants continually pursue growth strategies to establish a firm presence in the regional market. For instance, in July 2021, Nobel Hygiene in India bolstered its manufacturing capacity by inaugurating a new facility in the country to meet escalating demand.

Global Period Health Tech Market - Key Companies

1. Johnson & Johnson (US)
2. Procter & Gamble (US)
3. Kimberly-Clark (US)
4. EssityAktiebolag (publ) (Sweden)
5. Kao Corporation (Japan)
6. Daio Paper Corporation (Japan)
7. Unicharm Corporation (Japan)
8. Premier FMCG (South Africa)
9. Ontex (Belgium)
10. Hengan International Group Company Ltd. (China)
11. Drylock Technologies (Belgium)
12. Natracare LLC (US)
13. First Quality Enterprises, Inc. (US)
14. Bingbing Paper Co., Ltd. (China)

Recent Notable Events in the Global Period Health Tech Market:

• Merger & Acquisition:

In April 2021, Essity, a hygiene and health company, finalized an agreement to acquire approximately 44% of the Colombian hygiene firm Productos Familia S.A. ("Familia"). Following the completion of the acquisition, Essity will hold a minimum of 94% ownership in Familia, becoming its largest shareholder.

• Business Expansion:

In March 2021, Essity, a hygiene and health enterprise, expanded its range of sustainable products by introducing the Libresse V-Cup, a reusable menstrual cup, in Denmark, Finland, Norway, and Sweden.

• Merger & Acquisition:

In May 2020, Ontex announced its acquisition of the feminine hygiene manufacturing assets of AlbaadMassuot Yitzhak Ltd. in Rockingham County.